This type of cancer begins in the plasma cells, which are white blood cells that produce antibodies. It’s also known as Kahler Disease, myelomatosis and plasma cell myeloma.
Estimated new cases and deaths from multiple myeloma in the United States in 2015:
- New cases: 26,850
- Deaths: 11,240
- Kidney (renal) failure.
- Anemia-related fatigue.
- Bone damage and fractures.
Different types of treatment are available for patients with Multiple Myeloma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
For more information visit Cancer.gov’s Myeloma page